Mangalam Drugs and Organics share news and announcements
NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap
Last close ₹28.65down ₹0.92 (3.11%)BSE ₹28.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹29.57.
52-week range of traded prices to 23 Oct 2026
₹22.80Low, 29 Dec 2025₹71.99High, 23 Oct 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹45 Cr3,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 0.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −30.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −12.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 1.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 19,55176.4% delivered
Mangalam Drugs and Organics routine notices
100 filed, newest first. Page 2 of 2.
Sep 2023
7 Sep · Routine
Aug 2023
11 Aug · Routine
Jul 2023
Jun 2023
May 2023
31 May · Routine
Apr 2023
Mar 2023
30 Mar · Routine
14 Mar · Routine
Feb 2023
Jan 2023
Dec 2022
Nov 2022
14 Nov · Routine
Sep 2022
29 Sep · Routine
Jun 2022
Mar 2022
Jan 2022
Dec 2021
Oct 2021
Sep 2021
Jul 2021
Jun 2021
Apr 2021
Mar 2021
Dec 2020
Sep 2020
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Apr 2019
Jun 2016
May 2016
Jan 2016
Oct 2015
Aug 2015
Jul 2015
May 2015
5 May · Routine
In accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) regulations, 1992, the trading window for dealing in the securities of the Company will be closed for all Directors, officers and designated employees of the Company from May 7, 2015 and would open 24 hours after the announcement of financial results to the public.
Jan 2015
14 Jan · Routine
In accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) regulations, 1992, the trading window for dealing in the securities of the Company will be closed for all Directors, officers and designated employees of the Company from January 15, 2015 and would open 24 hours after the announcement of financial results to the public.
Nov 2014
4 Nov · Routine
Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) regulations, 1992, the trading window for dealing in the securities of the Company will be closed for all Directors, officers and designated employees of the Company from October 31, 2014 and would open 24 hours after the announcement of financial results to the public.